Concord Medical Services Holdings Limited
CCM · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $383,956 | $537,402 | $472,085 | $485,633 |
| % Growth | -28.6% | 13.8% | -2.8% | – |
| Cost of Goods Sold | $463,118 | $614,010 | $624,494 | $542,530 |
| Gross Profit | -$79,162 | -$76,608 | -$152,409 | -$56,897 |
| % Margin | -20.6% | -14.3% | -32.3% | -11.7% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $404,372 | $330,078 | $311,160 | $347,746 |
| SG&A Expenses | $452,998 | $386,377 | $372,639 | $401,421 |
| Sales & Mktg Exp. | $48,626 | $56,299 | $61,479 | $53,675 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $452,998 | $386,377 | $372,639 | $401,421 |
| Operating Income | -$532,160 | -$462,985 | -$525,048 | -$458,318 |
| % Margin | -138.6% | -86.2% | -111.2% | -94.4% |
| Other Income/Exp. Net | -$137,420 | -$92,609 | -$314,848 | -$70,919 |
| Pre-Tax Income | -$669,580 | -$555,594 | -$839,896 | -$529,237 |
| Tax Expense | -$17,505 | -$24,573 | -$70,906 | -$6,565 |
| Net Income | -$308,243 | -$297,658 | -$489,661 | -$271,427 |
| % Margin | -80.3% | -55.4% | -103.7% | -55.9% |
| EPS | -2,116.8 | -2,044.2 | -3,362.7 | -5,635.5 |
| % Growth | -3.6% | 39.2% | 40.3% | – |
| EPS Diluted | -2,116.8 | -2,044.2 | -3,362.7 | -5,635.5 |
| Weighted Avg Shares Out | 146 | 146 | 146 | 48 |
| Weighted Avg Shares Out Dil | 146 | 146 | 146 | 146 |
| Supplemental Information | – | – | – | – |
| Interest Income | $13,982 | $10,832 | $10,021 | $5,894 |
| Interest Expense | $193,199 | $165,669 | $120,357 | $73,789 |
| Depreciation & Amortization | $130,757 | $118,829 | $123,187 | $94,459 |
| EBITDA | -$345,624 | -$344,156 | -$401,861 | -$363,859 |
| % Margin | -90% | -64% | -85.1% | -74.9% |